Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stian Foss

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Immunological Reviews|October 27, 2015
TRIM21: a cytosolic Fc receptor with broad antibody isotype specificityStian Foss, Ruth Watkinson, Inger Sandlie, et al.
Frontiers in Immunology|September 27, 2019
TRIM21-From Intracellular Immunity to TherapyStian Foss, Maria Bottermann, Alexandra Jonsson, et al.
Scientific Reports|February 3, 2018
Pharmaceutical compounding of aflibercept in prefilled syringes does not affect structural integrity, stability or VEGF and Fc binding propertiesMagne Sand Sivertsen, Øystein Kalsnes Jørstad, Algirdas Grevys, et al.
Scientific Reports|November 25, 2016
Antibody-antigen kinetics constrain intracellular humoral immunityMaria Bottermann, Heidrun Elisabeth Lode, Ruth E Watkinson, et al.
The EMBO Journal|August 31, 2019
Antibody and DNA sensing pathways converge to activate the inflammasome during primary human macrophage infectionLarisa I Labzin, Maria Bottermann, Pablo Rodriguez-Silvestre, et al.
The Journal of Biological Chemistry|May 10, 2012
Anti-carcinoembryonic antigen single-chain variable fragment antibody variants bind mouse and human neonatal Fc receptor with different affinities that reveal distinct cross-species differences in serum half-lifeJan Terje Andersen, Stian Foss, Vania E Kenanova, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 1, 2016
Enhanced FcRn-dependent transepithelial delivery of IgG by Fc-engineering and polymerizationStian Foss, Algirdas Grevys, Kine Marita Knudsen Sand, et al.
The EMBO Journal|December 1, 2020
Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunitySarah L Caddy, Marina Vaysburd, Guido Papa, et al.
Cells|May 28, 2022
Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? <i>Cells</i> 2022, <i>11</i>, 942Anna Zakrzewicz, Celina Würth, Benedikt Beckert, et al.
Cells|March 25, 2022
Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus?Anna Zakrzewicz, Celina Würth, Benedikt Beckert, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Immunological Reviews|October 27, 2015
TRIM21: a cytosolic Fc receptor with broad antibody isotype specificityStian Foss, Ruth Watkinson, Inger Sandlie, et al.
Frontiers in Immunology|September 27, 2019
TRIM21-From Intracellular Immunity to TherapyStian Foss, Maria Bottermann, Alexandra Jonsson, et al.
Scientific Reports|February 3, 2018
Pharmaceutical compounding of aflibercept in prefilled syringes does not affect structural integrity, stability or VEGF and Fc binding propertiesMagne Sand Sivertsen, Øystein Kalsnes Jørstad, Algirdas Grevys, et al.
Scientific Reports|November 25, 2016
Antibody-antigen kinetics constrain intracellular humoral immunityMaria Bottermann, Heidrun Elisabeth Lode, Ruth E Watkinson, et al.
The EMBO Journal|August 31, 2019
Antibody and DNA sensing pathways converge to activate the inflammasome during primary human macrophage infectionLarisa I Labzin, Maria Bottermann, Pablo Rodriguez-Silvestre, et al.
The Journal of Biological Chemistry|May 10, 2012
Anti-carcinoembryonic antigen single-chain variable fragment antibody variants bind mouse and human neonatal Fc receptor with different affinities that reveal distinct cross-species differences in serum half-lifeJan Terje Andersen, Stian Foss, Vania E Kenanova, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 1, 2016
Enhanced FcRn-dependent transepithelial delivery of IgG by Fc-engineering and polymerizationStian Foss, Algirdas Grevys, Kine Marita Knudsen Sand, et al.
The EMBO Journal|December 1, 2020
Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunitySarah L Caddy, Marina Vaysburd, Guido Papa, et al.
Cells|May 28, 2022
Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? <i>Cells</i> 2022, <i>11</i>, 942Anna Zakrzewicz, Celina Würth, Benedikt Beckert, et al.
Cells|March 25, 2022
Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus?Anna Zakrzewicz, Celina Würth, Benedikt Beckert, et al.
Pageof 4